Overall growth of global pharmaceutical industry market performance of four countries is different

[market analysis of China Pharmaceutical network] the pharmaceutical industry is one of the key development areas of various countries In the era of growing demand for pharmaceutical products, what is the market trend of the pharmaceutical industry? The author understands that the scale of the global pharmaceutical industry keeps growing, the growth rate of emerging markets is relatively obvious, and the performance of the pharmaceutical industry in various countries has their own characteristics For example, China's pharmaceutical market is growing rapidly with a large overall demand for pharmaceuticals; Germany's chemical pharmaceutical industry has performed well; India's generic pharmaceutical market is bright; and Japan's R & D strength is strong According to the performance of four countries in the pharmaceutical industry, the author makes a sorting analysis China: the pharmaceutical industry with rigid demand will usher in a broader market space Some experts believe that the pharmaceutical industry in China is a growing industry with rigid demand Aging population, two child policy, economic development and other factors all make the demand for medical products continue to increase Not only that, with the transformation of medical and health mode from treatment oriented to prevention oriented, and the promotion of medical and health care integration, the pharmaceutical industry will usher in more and broader market space Taking the traditional Chinese medicine industry as an example, the 13th five year plan outline for national economic and social development, the notice on printing and distributing the development plan for health services of traditional Chinese medicine (2015-2020), the quality management standard for production of traditional Chinese medicine, etc clearly stipulate the development purpose of traditional Chinese Medicine industry, and include traditional Chinese medicine in the plan for national economic and social development Under the promotion of these policies, the traditional Chinese medicine industry has not only got standardized development, but also the traditional Chinese medicine enterprises are becoming stronger and bigger, such as Kangmei pharmaceutical, Yunnan Baiyao, Tongrentang, dong'a-jiao, etc It is worth mentioning that some traditional Chinese medicine enterprises also extend their business to develop in the field of health, so as to improve the economic benefits of enterprises and boost the development of the industry Germany: the chemical and pharmaceutical industry achieved significant growth According to the new data released by the German chemical association, the output of the chemical and pharmaceutical industry in Germany increased by 3.8% in 2017, exceeding expectations; the total sales revenue reached 19.8 billion euros, an increase of 6% The German chemical industry association also predicted the development of the chemical and pharmaceutical industry in 2018 It is reported that in 2018, the output of the chemical and pharmaceutical industry in Germany may increase by 3.5%, and the sales revenue is expected to increase by 4.5%, which is expected to exceed 204 billion euros In 2017, the overall performance of German chempharma was gratifying, especially in the fourth quarter, with a relatively strong development The author understands that chemical and pharmaceutical industry is the third largest industrial sector in Germany Last year, the overseas sales revenue of German chemical and pharmaceutical enterprises reached 120.7 billion euros, an increase of 6.6% year on year, accounting for 61.6% of the total revenue India: a large number of generic drugs can be listed quickly in line with European and American policies India is a big country of generic drugs, especially the achievements in recent years, which further affirmed the title of India's big country of generic drugs Industry insiders said that one of the reasons why India's generic drugs are developed is that the policy is in line with Europe and the United States, which allows a large number of generic drugs to be listed soon For example, the be test required for oral preparations can be carried out in India without too complicated administrative approval process, and the experimental data are also recognized by Europe and the United States Not only that, some say, India's cancer drugs are also a big advantage India's generic drugs can control production costs and reduce prices to less than a third Japan: the R & D ability of pharmaceutical enterprises with strong policy can not be ignored, and Japan attaches great importance to the R & D of innovative drugs Under the strategic background of "building the country through biotechnology industry", the Japanese government has issued a series of policies to encourage domestic innovative drug research and development Specifically, it can be divided into three categories: intellectual property policy, drug regulation policy and tax financial policy In addition, the R & D ability of Japanese pharmaceutical companies to innovative drugs can not be ignored The author understands that in order to increase the R & D strength, Japanese pharmaceutical enterprises also mostly choose joint ventures and equity participation to set up R & D centers to improve the level and level of R & D In addition, Japanese pharmaceutical companies have accelerated the pace of global distribution, reduced their dependence on the local market, and gradually entered the foreign market They have found a way of development, and created pharmaceutical companies such as Japan's Weicai, Takeda pharmaceutical industry, Astaire, Otsuka pharmaceutical, etc Conclusion: the development of pharmaceutical industry in each country has its own characteristics Under the situation of increasing global pharmaceutical competition, it is necessary for many pharmaceutical enterprises to grasp the development trend of global pharmaceutical industry in combination with their own reality In addition, whether we can enlarge our own advantages, gather the advantages of resources, talents, policies and other advantages to promote the rapid development of the pharmaceutical industry is the content that every country should think about.